bioRxivGeneticsPreprint
Introduction of Dicistrovirus IRESs into UAS/SV40-polyA constructs results in premature polyadenylation and strong overexpression of the upstream ORF in Drosophila animals.
Abstract
To evaluate the properties of insect virus internal ribosomal entry sites (IRESs) for protein expression in Drosophila, we have introduced Cricket Paralysis virus (CrPV) and Drosophila C virus (DCV) IRESs into UAS/SV40-polyA vector. We found that introduction of IRESs induce premature polyadenylation, resulting in both truncation of the mRNA, and an increase in mRNA levels of approximately 40-fold. The increase in mRNA levels was accompanied by increased resistance to nonsense-mediated mRNA decay (NMD)-mediated degradation. Our results suggest that premature polyadenylation increases mRNA stability in the SV40 polyadenylation site-containing constructs, suggesting a novel method for robust overexpression of transgenes in Drosophila.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Robust expression of transgenes in Drosophila melanogaster
Peter V. Lidsky, Sergey E. Dmitriev, Raul Andino·bioRxiv·Oct 30, 2022
- IRES-mediated ribosome repositioning directs translation of a +1 overlapping ORF that enhances viral infection
C. H. Kerr, Q. S. Wang, … E. Jan·bioRxiv·Jun 27, 2018
- Enhancement of synthetic mRNA translation efficiency through engineered poly(A) tails
Yusheng Liu, Hu Nie, … Falong Lu·bioRxiv·Aug 30, 2021
- Resurrection of a viral internal ribosome entry site from a 700 year old ancient Northwest Territories cripavirus
- The Israeli Acute Paralysis Virus IRES captures host ribosomes by mimicking a ribosomal state with hybrid tRNAs.
I. Fernandez, J. Frank, … R. Neupane·bioRxiv·Apr 11, 2019
- The pupal stage is a developmental window for RNA virus persistence in Drosophila
Mauro Castelló-Sanjuán, Rubén González, … Maria‐Carla Saleh·bioRxiv·Nov 7, 2025